Hope in the Pipeline

Better treatments begin with research. Learn how psychiatric clinical trials are helping shape the future of bipolar disorder care. 🌐 Website: preferredresearchpartners.com ✉️ Email: info@preferredresearchpartners.com 📞 Phone: (501) 553-9987 📍 Address: 11219 Financial Centre Parkway, Suite 320, Little Rock, AR 72211

Headaches in children affect more than physical health—they impact school, social life, emotional well-being, and family dynamics. This episode explores the full picture of pediatric migraine burden. #MentalHealth #ChildWellbeing #Migraine #ClinicalTrials #MedicalResearch #MigraineResearch #pediatrics  🌐 Website: preferredresearchpartners.com ✉️ Email: info@preferredresearchpartners.com 📞 Phone:...

ADHD is more than “being hyper.” In this powerful discussion, Dr. Paul Wylie and David Weed explain how ADHD impacts children emotionally, academically, socially, and even physically through sleep and behavioral challenges. Learn about: Hidden signs of inattentive ADHD Hyperactivity and impulsive behavior ADHD and low self-esteem Why some children struggle in school despite high intelligence Medic...

Discover exciting new developments at Preferred Research Partners, including our new IV infusion suite, expanded clinical trial capabilities, and the introduction of Dr. David Weed to the team.

Have you or a loved one experienced ongoing abdominal pain, fatigue, or digestive issues like diarrhea or loss of appetite? You may be living with one of the lifelong conditions known as Inflammatory Bowel Disease (IBD), which includes Crohn’s disease and ulcerative colitis. In this episode of Hope in the Pipeline, Dr. Paul Wylie, Medical Director of Preferred Research Partners in Little Rock, Ark...

For this episode of Hope in the Pipeline, Dr. Wylie is joined by one of our Clinical Research Coordinators, Jessica Watson. They talk about gastroparesis clinical trials, and Jessica explains what a research trial looks like. Interested in learning more? Visit our website for more information about clinical research trials: www.preferredresearchpartners.com

Gastroparesis affects about 5 million people in the U.S. — causing nausea, stomach pain, bloating, and more. In this episode of Hope in the Pipeline, Dr. Paul Wy shares how clinical trials are leading the way to better treatments and why participation matters. Together, we can bring hope to millions.

Welcome to the third part of our Hope in the Pipeline series on hypersomnolence disorders. In this episode, we dive deep into:   🔹 Medications used to treat narcolepsy – from older stimulants to newer, longer-lasting options 🔹 The role of antidepressants and sodium oxybate in managing symptoms like cataplexy 🔹 Key differences between narcolepsy and idiopathic hypersomnia (IH) 🔹 Current treatme...

Welcome back to Hope in the Pipeline! In this episode, we continue our deep dive into narcolepsy, exploring: ✅ What causes cataplexy (sudden loss of muscle tone) ✅ How dream sleep paralysis can leak into wakefulness ✅ Vivid sleep-related hallucinations and automatic behaviors ✅ The detailed diagnostic process for narcolepsy, including sleep studies and genetic testing ✅ How narcolepsy impacts...

Have you ever felt overwhelmingly sleepy even after a full night’s rest? Narcolepsy and idiopathic hypersomnia are two central disorders of hypersomnolence that affect millions worldwide — often undiagnosed. In this episode of Hope in the Pipeline, we explore: 🧠 What narcolepsy and idiopathic hypersomnia are 🧠 Key symptoms and differences between the two 🧠 Causes, diagnosis, and treatment optio...

Did you know that the number of blood pressure medications you take could be a sign of untreated obstructive sleep apnea? There is a strong connection between obstructive sleep apnea (OSA) and hypertension, including the serious health risks of untreated OSA—from stroke and dementia to heart failure and even death. In this episode, Dr. Paul Wylie discusses a new clinical trial testing a promising...

Did you know that 12% of women experience chronic or episodic migraines, and for many, they’re tied to hormonal cycles? In this episode of Hope in the Pipeline, Dr. Paul Wylie dives into the causes, symptoms, and treatments of menstrual migraines. 🧠In this episode, you’ll learn: What causes menstrual migraines (hint: estrogen & hormone changes) How they differ from common migraines Why they o...

In this episode of Hope in the Pipeline, Dr. Paul Wylie dives deep into chronic insomnia disorder—what causes it, how it affects both children and adults, and the latest research aimed at treating it. 🧠 Learn about: The types of insomnia symptoms Differences in diagnosing pediatric vs. adult insomnia Behavioral vs. pharmacological treatments The real-life impact of chronic sleep disruption Two ne...

Attention Deficit Hyperactivity Disorder (ADHD) affects millions of children — but early diagnosis and the right treatment can make a world of difference. In this episode of Hope in the Pipeline, Dr. Paul Wylie, Neuropsychiatry and Sleep Medicine Specialist, explores the symptoms, causes, and treatment options for pediatric ADHD. We also dive into an exciting new clinical research trial for childr...

In this episode of Hope in the Pipeline, Dr. Paul Wylie discusses pediatric migraines, their prevalence, symptoms, and treatment options. He highlights the importance of understanding how migraines affect children differently than adults and the potential for clinical trials to improve treatment outcomes. The conversation emphasizes the need for awareness and research in managing pediatric migrain...

In this episode of Hope in the Pipeline, Dr. Paul Wylie sheds light on narcolepsy—a complex neurological sleep disorder marked by overwhelming daytime sleepiness and sudden muscle weakness known as cataplexy. He breaks down the different types of narcolepsy, explores its symptoms, and dives into the science behind it, from genetic links to autoimmune triggers. The conversation also highlights curr...

#ShiftWork #SWSD #SleepDisorder   Millions of workers rely on shift work to keep essential services running, but at what cost? Dr. Paul Wylie, a Neuropsychiatry and Sleep Medicine Specialist, dives into Shift Work Sleep Disorder (SWSD)—its impact on sleep, productivity, and long-term health risks like mood disorders, diabetes, and even cancer. Preferred Research Partners is currently enrolling par...

An in-depth exploration of social anxiety disorder and generalized anxiety disorder, discussing their symptoms, prevalence, and the impact they have on individuals' lives. Dr. Paul Wylie shares insights into the causes, treatment options, and the importance of clinical trials in advancing mental health care. The discussion highlights the innovative treatments being tested to improve the quality of...

This conversation explores the emerging field of psychedelic research in mental health, focusing on the potential of psychedelic medications to treat mood disorders. Dr. Paul Wylie, a neuropsychiatrist, discusses the historical context of mental health treatments, the evolution of psychedelics in therapy, and the mechanisms by which they may promote neuroplasticity and improve mental health outcom...